Micas Pedersen, Signe http://orcid.org/0009-0008-3418-422X
Feltoft, Claus Larsen
Nielsen, Torsten Holm
de Nully Brown, Peter http://orcid.org/0000-0002-6522-4086
Gang, Anne Ortved http://orcid.org/0000-0003-0160-1257
Pedersen, Lars Møller http://orcid.org/0000-0002-9419-8841
Jørgensen, Niels http://orcid.org/0000-0003-4827-0838
Funding for this research was provided by:
Rigshospitalet
Fabrikant Einar Willumsens Mindelegat
Jens and Maren Thestrups Scholarship
Johannes Fog Fund
Royal Library, Copenhagen University Library
Article History
Received: 6 September 2023
Accepted: 12 October 2023
First Online: 23 October 2023
Declarations
:
: All participants consented to participate and for publication of results. Consent forms, clinical and sociodemographic data, and hormonal results were registered digitally on the secure data capture platform REDCap (Research Electronic Data Capture) for the Capital Region of Denmark [CitationRef removed, CitationRef removed]. The study was performed in accordance with the Declaration of Helsinki. Approval by the Danish Regional Committee on Health Research Ethics, Capital Region of Denmark (case number: H-20036508) and the Danish Capital Region Knowledge Center for Data Reviews (case number: P-2020–827) was obtained. This report complies with the STROBE guidelines.
: Besins Healthcare supplied the Investigational Medicinal Product, Testogel, for another study conducted by the lead author. However, no additional financial support was received from Besins Healthcare, and the authors retained full ownership of all data and publication rights for all studies conducted. The content of this article was not subject to any control or influence by Besins Healthcare. PNB is on the advisory board for Roche, Gilead, and Swedish Orphan. None of the stated medical companies has been involved in this study and had no control or influence over the content.